MRVI news

Latest 1 stories · newest Aug 6, 2026

MRVI

Maravai reports Q2 2026 revenue up 9% and raises EBITDA guidance

Maravai LifeSciences reported $51.4 million in second quarter 2026 revenue and raised its full-year Adjusted EBITDA guidance, citing growth in its TriLink and Cygnus segments.

Earnings Aug 6, 2026 sentiment +0.25 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same MRVI feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/MRVI/newsSTART FREE